Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry Melim

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Current Osteoporosis Reports|September 16, 2011
Rodent models of aging bone: an updateFarhan A Syed, Terry Melim
Frontiers in Immunology|March 1, 2021
Optimized Culture Conditions for Improved Growth and Functional Differentiation of Mouse and Human Colon OrganoidsSarah S Wilson, Martha Mayo, Terry Melim, et al.
Advances in Therapy|April 30, 2017
RPC4046, A Novel Anti-interleukin-13 Antibody, Blocks IL-13 Binding to IL-13 α1 and α2 Receptors: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation First-in-Human StudyCatherine S Tripp, Carolyn Cuff, Andrew L Campbell, et al.
Plos One|September 8, 2018
Prodrugs for colon-restricted delivery: Design, synthesis, and in vivo evaluation of colony stimulating factor 1 receptor (CSF1R) inhibitorsDawn M George, Raymond J Huntley, Kevin Cusack, et al.
Immunohorizons|March 26, 2026
Direct contact with natural killer cells reprograms monocyte-derived dendritic cells into a tolerogenic phenotypeAmmar J Alsheikh, Liang Chen, Daniel Korenfeld, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Current Osteoporosis Reports|September 16, 2011
Rodent models of aging bone: an updateFarhan A Syed, Terry Melim
Frontiers in Immunology|March 1, 2021
Optimized Culture Conditions for Improved Growth and Functional Differentiation of Mouse and Human Colon OrganoidsSarah S Wilson, Martha Mayo, Terry Melim, et al.
Advances in Therapy|April 30, 2017
RPC4046, A Novel Anti-interleukin-13 Antibody, Blocks IL-13 Binding to IL-13 α1 and α2 Receptors: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation First-in-Human StudyCatherine S Tripp, Carolyn Cuff, Andrew L Campbell, et al.
Plos One|September 8, 2018
Prodrugs for colon-restricted delivery: Design, synthesis, and in vivo evaluation of colony stimulating factor 1 receptor (CSF1R) inhibitorsDawn M George, Raymond J Huntley, Kevin Cusack, et al.
Immunohorizons|March 26, 2026
Direct contact with natural killer cells reprograms monocyte-derived dendritic cells into a tolerogenic phenotypeAmmar J Alsheikh, Liang Chen, Daniel Korenfeld, et al.
Pageof 1